Jason Haas Insider Profile
11 Followers
Jason Haas, CFO at Syros Pharmaceuticals, holds 4.98K shares in Ligand Pharma (Ticker: LGND), holds 62.91K shares in Odyssey Therapeutics, Inc. (Ticker: ODTX), holds 0.00 shares in Syros Pharmaceuticals (Ticker: SYRS).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-42.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jason Haas holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jason Haas
Jason Haas's Trading History
Syros Pharmaceuticals
Nov 20, 2024
CFO
Informative Sell
28.94K
$0.00
Ligand Pharma
Jun 15, 2026
Director
Uninformative Buy
206.24K
$1.37M
Odyssey Therapeutics, Inc.
May 11, 2026
Chief Financial Officer
Informative Buy
20.00K
$1.20M
List of latest transactions for each holding click on a transaction to see Jason Haas's performance on stock
You May Also Like
Jason Haas insider profile FAQ
What is the percentage of profitable transactions made by Jason Haas?
The percentage of profitable transactions made by Jason Haas is 0%.
What is the average return per transaction made by Jason Haas?
The average return per transaction made by Jason Haas is -42.30%.
What stocks does Jason Haas hold?
Jason Haas holds: SYRS, LGND, ODTX stocks.
What was Jason Haas’s latest transaction?
Jason Haas latest transaction was an Uninformative Buy of $206.24K.
What was Jason Haas's most profitable transaction?
Jason Haas’s most profitable transaction was an Informative Buy of ODTX stock on May 11, 2026. The return on the trade was -3.10%.
What is Jason Haas's role in Syros Pharmaceuticals?
Jason Haas's role in Syros Pharmaceuticals is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.